Year To Quarter End Consolidated Statement Of Comprehensive Income

Mochida Pharmaceutical Co.,Ltd. - Filing #7537456

Concept 2023-04-01 to
2023-09-30
2022-04-01 to
2022-09-30
Year to quarter end consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
2,838,000,000 JPY
3,923,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
2,105,000,000 JPY
-511,000,000 JPY
Remeasurements of defined benefit plans, net of tax
-22,000,000 JPY
-21,000,000 JPY
Other comprehensive income
2,082,000,000 JPY
-533,000,000 JPY
Comprehensive income
4,921,000,000 JPY
3,389,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
4,921,000,000 JPY
3,389,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.